Latest Period
Q2 2026
Security Snapshot
Profound Medical Corp. - Common Shares (PROF) Institutional Ownership
CUSIP: 74319B502
13F Institutional Holders and Ownership History from Q4 2019 to Q2 2026
Institutions Reporting
56
Shares (Excl. Options)
16,057,630
Price
$6.65
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- PROF on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 16,057,630
- Total 13F value
- $105,771,425
- Portfolio coverage rank
- 0%
- Share change
- +49,167
- Value change
- +$354,487
- Number of holders
- 56
- Shares outstanding
- 29,881,634
- SEC-reported price per share
- $7.24
- Insider filing price
- $7.24
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PROF - Profound Medical Corp. - Common Shares is tracked under CUSIP 74319B502.
- 56 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 57 to 56 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $105,590,763 to $105,771,425.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 56 institutions filings for Q2 2026.
Security key
74319B502
Latest holder period
Q2 2026
13F holders
56
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
PROF full holder history
Profound Medical Corp. SEC filings
Profound Medical Corp. company facts
Profound Medical Corp. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74319B502:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
PROF
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GAGNON SECURITIES LLC | 11% | $15,796,627 | 3,346,743 | Neil Gagnon | 31 Dec 2024 |
As of 30 Jun 2026, 56 institutional investors reported holding 16,057,630 shares of Profound Medical Corp. - Common Shares (PROF). This represents 54% of the company’s total 29,881,634 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
52%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FIL Ltd | 7.9% | 2,370,000 | +1.3% | 0.01% | $15,760,496 |
| GAGNON SECURITIES LLC | 6.6% | 1,960,074 | +0.81% | 2.5% | $13,034,492 |
| ROYCE & ASSOCIATES LP | 4% | 1,199,564 | +7.5% | 0.06% | $7,975,948 |
| Timelo Investment Management Inc. | 3.7% | 1,114,967 | 0% | 9.3% | $7,414,531 |
| Gagnon Advisors, LLC | 3.2% | 962,186 | 0% | 4.1% | $6,398,537 |
| LETKO, BROSSEAU & ASSOCIATES INC | 3.1% | 935,725 | -1.8% | 0.08% | $5,403,226 |
| Rosalind Advisors, Inc. | 2.8% | 828,118 | 0% | 2.1% | $5,506,985 |
| Z3 Capital Partners, LLC | 2.7% | 820,941 | +0.36% | 1.1% | $5,459,258 |
| MMCAP International Inc. SPC | 2.2% | 671,356 | -9.9% | 0.38% | $4,464,517 |
| ARDSLEY ADVISORY PARTNERS LP | 1.9% | 575,000 | 0% | 0.42% | $3,823,750 |
| Ring Mountain Capital, LLC | 1.7% | 511,917 | +0.16% | 1.4% | $3,404,248 |
| Lagoda Investment Management, L.P. | 1.7% | 501,325 | +14% | 1.8% | $3,333,811 |
| ROYAL BANK OF CANADA | 1.6% | 491,495 | -0.32% | 0% | $3,268,000 |
| First Eagle Investment Management, LLC | 1.5% | 440,207 | +36% | 0% | $2,927,377 |
| DAFNA Capital Management LLC | 0.87% | 260,360 | -1% | 0.33% | $1,731,394 |
| Bleichroeder LP | 0.85% | 254,753 | 0% | 0.3% | $1,694,107 |
| FORMULA GROWTH LTD | 0.8% | 240,088 | -0.44% | 0.56% | $1,596,585 |
| NATIONAL BANK OF CANADA /FI/ | 0.73% | 218,698 | +0.7% | 0% | $1,248,927 |
| THOMPSON DAVIS & CO., INC. | 0.72% | 216,535 | +0.35% | 0.86% | $1,439,958 |
| Dauntless Investment Group, LLC | 0.7% | 208,369 | -13% | 2.4% | $1,385,654 |
| RAYMOND JAMES FINANCIAL INC | 0.63% | 189,116 | +26% | 0% | $1,257,622 |
| CM Management, LLC | 0.59% | 175,000 | 0% | 0.74% | $1,163,750 |
| Velan Capital Investment Management LP | 0.57% | 170,278 | -40% | 0.69% | $1,132,349 |
| TD Waterhouse Canada Inc. | 0.46% | 138,110 | -3.4% | 0% | $933,554 |
| PERKINS CAPITAL MANAGEMENT INC | 0.38% | 114,280 | 0% | 0.57% | $759,962 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
27
Latest
Q2 2026
Rows shown
1-25 of 27
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 16,057,630 | $105,771,425 | +$354,487 | $6.65 | 56 |
| 2026 Q1 | 16,337,804 | $105,590,763 | -$569,539 | $6.48 | 57 |
| 2025 Q4 | 16,057,288 | $126,309,609 | +$31,389,798 | $7.87 | 63 |
| 2025 Q3 | 11,063,194 | $54,283,775 | -$7,406,922 | $4.89 | 43 |
| 2025 Q2 | 12,482,340 | $73,650,616 | -$2,042,016 | $5.90 | 44 |
| 2025 Q1 | 12,825,851 | $73,303,109 | -$7,205,786 | $5.82 | 48 |
| 2024 Q4 | 13,763,555 | $102,960,287 | +$30,141,003 | $7.51 | 51 |
| 2024 Q3 | 9,406,781 | $74,869,184 | -$1,117,706 | $7.96 | 42 |
| 2024 Q2 | 9,510,240 | $80,047,787 | -$132,453 | $8.39 | 37 |
| 2024 Q1 | 9,500,142 | $80,114,995 | +$2,238,848 | $8.53 | 39 |
| 2023 Q4 | 9,251,176 | $77,759,535 | +$10,244,275 | $8.49 | 45 |
| 2023 Q3 | 7,489,374 | $75,450,155 | -$1,487,679 | $10.20 | 30 |
| 2023 Q2 | 7,634,234 | $98,724,050 | -$1,129,044 | $13.01 | 29 |
| 2023 Q1 | 7,726,121 | $71,704,219 | -$6,964,776 | $9.29 | 30 |
| 2022 Q4 | 8,472,949 | $91,726,796 | +$3,083,523 | $10.89 | 33 |
| 2022 Q3 | 8,745,198 | $35,381,959 | -$177,655 | $4.04 | 30 |
| 2022 Q2 | 8,675,590 | $63,032,248 | -$3,670,846 | $7.29 | 34 |
| 2022 Q1 | 9,402,835 | $84,635,691 | -$3,611,432 | $9.00 | 41 |
| 2021 Q4 | 9,774,988 | $109,777,858 | -$2,915,423 | $11.24 | 44 |
| 2021 Q3 | 8,722,358 | $127,589,352 | -$1,309,423 | $14.64 | 46 |
| 2021 Q2 | 8,722,951 | $142,593,346 | -$126,994 | $16.36 | 46 |
| 2021 Q1 | 8,673,835 | $174,440,609 | +$8,178,699 | $20.14 | 52 |
| 2020 Q4 | 8,182,487 | $168,377,436 | +$26,332,305 | $20.56 | 53 |
| 2020 Q3 | 7,009,150 | $123,510,789 | +$42,298,243 | $17.64 | 44 |
| 2020 Q2 | 4,612,581 | $78,146,000 | -$131,017 | $16.94 | 33 |